This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Technion Research & Development Foundation Ltd, Tel Aviv University, Other. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,004 
1 out of 841 
1 out of 834,513 Years Active: 2025-2026
Title: David Meiri: Innovator in Cannabinoid Research
Introduction
David Meiri is a prominent inventor based in Haifa, Israel. He has made significant contributions to the field of cannabinoid research, particularly in the development of pharmaceutical compositions that utilize cannabinoids for therapeutic purposes. His work is paving the way for innovative treatments for various diseases.
Latest Patents
David Meiri holds a patent titled "Cannabinoids and uses thereof." This invention provides a pharmaceutical composition that includes a combination of at least two cannabinoids. The methods of using this composition are aimed at treating diseases related to NOTCH 1, showcasing the potential of cannabinoids in medical applications. He has 1 patent to his name.
Career Highlights
Throughout his career, David has been associated with notable institutions such as the Technion Research & Development Foundation Ltd and Tel Aviv University. His work at these organizations has allowed him to explore the therapeutic potential of cannabinoids extensively.
Collaborations
David has collaborated with several professionals in his field, including Paula Berman and Igal Louria-Hayon. These partnerships have contributed to the advancement of his research and the development of innovative solutions in cannabinoid therapy.
Conclusion
David Meiri's work in cannabinoid research exemplifies the intersection of innovation and medicine. His contributions are significant in the ongoing exploration of cannabinoid applications for treating complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile